Medical Supplies and Biosciences. Safe dividend, in uptrend prior to market correction.

Strong stock in a declining market. The company now sees full-year revenue of between $810 million and $820 million and earnings per share of $1.89 to $1.93. Analysts polled by Thomson Financial expect earnings of $1.56 a share and revenue of $712.2 million. The stock closed up $4.83 to $55.42, well above its 52-week high.

Strong performer in down market. Strong prospective growth to PE. Expects 4th Q earnings above analysts expectations.

Replaces swhc

A prison company with facilities in the United States, Australia, Canada, South Africa, and the U.K. More of a longer term pick as costs for additional facilities may delay the incremental income expected from a new contract.